Hereditary hemochromatosis is an inherited tendency to absorb and retain too much iron. An HFE result identifies part of that tendency; blood tests and, when needed, organ assessment establish whether iron is actually accumulating. A high ferritin result alone does not diagnose hereditary hemochromatosis, and an HFE variant alone does not establish organ damage.

This distinction matters when a routine blood test, a relative’s diagnosis or a genetic report starts the investigation. The steps below explain how to bring those findings together. The examples are fictional and illustrate interpretation, not individual treatment plans.

Ferritin and transferrin saturation answer different questions

Transferrin saturation (TSAT) describes how much of the blood’s iron-binding capacity is occupied. Ferritin helps assess iron stores, but can also rise with inflammation, liver injury and other conditions. Read both with the laboratory’s reference ranges, previous results and clinical history. The NHS diagnostic overview explains the sequence from blood tests to genetic and liver assessment.

Transferrin saturation assesses occupied iron-binding capacity in blood. Ferritin helps assess stores but also rises with inflammation and liver injury. The schematic occupancy and iron dots are not laboratory values.
Transferrin saturation assesses occupied iron-binding capacity in blood. Ferritin helps assess stores but also rises with inflammation and liver injury. The schematic occupancy and iron dots are not laboratory values.

Open full-size illustration (new tab)

Example: an elevated result after illness. Maya’s ferritin is above her laboratory’s range shortly after an infection, while TSAT is not elevated. She asks whether she should start giving blood to remove iron. The useful next question is what explains the pattern: her clinician may review the illness, liver results, medicines and supplements, and arrange reassessment. The isolated ferritin result does not demonstrate the iron-loading disorder that her internet search suggested.

What C282Y and H63D mean on an HFE report

C282Y is shorthand for p.Cys282Tyr; H63D means p.His63Asp. Homozygous means that the same variant is present in both gene copies. Compound heterozygous means different variants are present on the two copies. The HFE GeneReviews chapter distinguishes non-penetrant, biochemical and clinical disease: these are not interchangeable outcomes.

Report findingUseful interpretationWhat it does not establish
C282Y/C282YThe principal HFE genotype associated with hemochromatosis; assess iron indices and clinical context.That organ damage is present or inevitable.
C282Y/H63DA substantially lower-penetrance genotype; investigate the actual iron phenotype and other contributors.That raised ferritin automatically requires iron-removal treatment.
H63D/H63D or one common HFE variantUsually does not explain clinically important iron overload by itself.That unexplained abnormal results should be dismissed.
No common HFE variants detectedThe particular variants tested were not found.That every inherited or acquired cause of iron overload was excluded.

Example: the same genotype, different outcomes. Two siblings have C282Y/C282Y. One has normal ferritin; the other has persistent biochemical iron loading. They share a genotype, but their present clinical questions differ. The first needs an agreed monitoring plan; the second needs assessment of iron burden and possible complications. Neither should copy the other’s treatment schedule. See penetrance versus expressivity for the distinction between having a predisposition and developing its manifestations.

Why H63D should not become a diagnosis by itself

A longitudinal study of C282Y/H63D compound heterozygotes found that this was a low-penetrance genotype for iron-overload-related disease. That finding does not mean that every individual with this result has zero risk; it means that genotype must be interpreted alongside the evidence of iron loading.

Example: C282Y/H63D with raised ferritin. Daniel has this genotype, metabolic risk factors and abnormal liver tests. Rather than attributing everything to HFE, the clinician separates three questions: Is excess iron present? What else may be contributing to the liver findings? Is there fibrosis? These questions may require different investigations.

The EASL hemochromatosis guideline recommends confirming hepatic iron overload in relevant patients whose findings do not fit the typical C282Y-homozygous pathway. MRI can quantify liver iron; biopsy is reserved for selected situations. Assessing iron and assessing liver scarring are related but distinct tasks. For C282Y/H63D or H63D/H63D with confirmed overload, treatment decisions require individual assessment rather than a genetic label alone.

What if the HFE result does not explain the iron overload?

First establish what was tested. A common-variant assay is not the same as sequencing HFE, and neither is a comprehensive test for every iron disorder. In selected patients with convincing unexplained iron loading, specialist assessment may consider genes such as HJV, HAMP, TFR2 or SLC40A1. Their mechanisms and inheritance are not all identical. Broad testing is not automatically the next step for every raised ferritin result.

Acquired iron overload also matters. Repeated transfusions can add iron independently of an HFE diagnosis. The NIDDK explanation of causes distinguishes hereditary and secondary iron overload. Our beta thalassemia guide discusses a different setting in which iron assessment is important.

Example: a negative common-variant panel. A patient with substantial MRI-confirmed liver iron has a report stating “C282Y and H63D not detected.” A useful referral includes the MRI report, serial iron indices, transfusion history, liver findings and the exact genetic assay. “All genetic causes excluded” would overstate that report. The negative genetic test guide explains this limitation.

Family testing and the appointment checklist

HFE-related hemochromatosis usually follows autosomal recessive inheritance. Family assessment should use the affected relative’s confirmed result and the clinical context, not just a family story of “high iron.” The NHS genomics guide discusses counselling and family testing.

  1. Bring the full genotype report and dated ferritin and TSAT results, including units and reference ranges.
  2. List transfusions, supplements, alcohol intake, relevant illnesses and known liver conditions.
  3. Ask whether the current finding is genetic susceptibility, biochemical iron loading or established organ disease.
  4. Ask what needs monitoring, who will arrange it and what would change the plan.
  5. Discuss which relatives would benefit from testing and which test answers their question.

The variant research worksheet can help organize the report terminology. Use the genetics care finder when family-risk questions need specialist discussion; iron overload itself may also require hepatology or hematology care.